These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 2652252)

  • 1. The BCG story: lessons from the past and implications for the future.
    Fine PE
    Rev Infect Dis; 1989; 11 Suppl 2():S353-9. PubMed ID: 2652252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi.
    Pönnighaus JM; Fine PE; Sterne JA; Wilson RJ; Msosa E; Gruer PJ; Jenkins PA; Lucas SB; Liomba NG; Bliss L
    Lancet; 1992 Mar; 339(8794):636-9. PubMed ID: 1347338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does bacille Calmette-Guérin scar size have implications for protection against tuberculosis or leprosy?
    Sterne JA; Fine PE; Pönnighaus JM; Sibanda F; Munthali M; Glynn JR
    Tuber Lung Dis; 1996 Apr; 77(2):117-23. PubMed ID: 8762845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deciphering the story of Bacillus Calmette Guerin (BCG) vaccine in prevention of leprosy.
    Zodpey SP
    Indian J Public Health; 2006; 50(2):67-9. PubMed ID: 17191407
    [No Abstract]   [Full Text] [Related]  

  • 5. New strategies for leprosy and tuberculosis and for development of bacillus Calmette-Guérin into a multivaccine vehicle.
    Bloom BR; Jacobs WR
    Ann N Y Acad Sci; 1989; 569():155-73. PubMed ID: 2516995
    [No Abstract]   [Full Text] [Related]  

  • 6. The BCG controversy: a reappraisal of the protective effect against tuberculosis and leprosy.
    Zodpey SP
    Indian J Public Health; 2004; 48(2):70-7. PubMed ID: 15709589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity.
    Fine PE; Sterne JA; Pönnighaus JM; Rees RJ
    Lancet; 1994 Nov; 344(8932):1245-9. PubMed ID: 7967984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-Generation Vaccines Based on Bacille Calmette-Guérin.
    Nieuwenhuizen NE; Kaufmann SHE
    Front Immunol; 2018; 9():121. PubMed ID: 29459859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?
    Moliva JI; Turner J; Torrelles JB
    Vaccine; 2015 Sep; 33(39):5035-41. PubMed ID: 26319069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New antituberculosis vaccines].
    Locht C; Rouanet C
    Arch Pediatr; 2011 Sep; 18(9):1023-7. PubMed ID: 21676602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dream of a vaccine against tuberculosis; new vaccines improving or replacing BCG?
    Martín C
    Eur Respir J; 2005 Jul; 26(1):162-7. PubMed ID: 15994403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scar size and effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of tuberculosis and leprosy: a case-control study.
    Zodpey SP; Shrikhande SN; Kulkarni SW; Maldhure BR
    Indian J Public Health; 2007; 51(3):184-9. PubMed ID: 18229442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in the development and testing of vaccines against human tuberculosis.
    McMurray DN
    Int J Parasitol; 2003 May; 33(5-6):547-54. PubMed ID: 12782054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccines for Leprosy and Tuberculosis: Opportunities for Shared Research, Development, and Application.
    Coppola M; van den Eeden SJF; Robbins N; Wilson L; Franken KLMC; Adams LB; Gillis TP; Ottenhoff THM; Geluk A
    Front Immunol; 2018; 9():308. PubMed ID: 29535713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of bacille Calmette-Guerin vaccine strain on the immune response against tuberculosis: a randomized trial.
    Ritz N; Dutta B; Donath S; Casalaz D; Connell TG; Tebruegge M; Robins-Browne R; Hanekom WA; Britton WJ; Curtis N
    Am J Respir Crit Care Med; 2012 Jan; 185(2):213-22. PubMed ID: 22071384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group.
    Lancet; 1996 Jul; 348(9019):17-24. PubMed ID: 8691924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCG vaccination against tuberculosis: past disappointments and future hopes.
    Roche PW; Triccas JA; Winter N
    Trends Microbiol; 1995 Oct; 3(10):397-401. PubMed ID: 8564359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA encoding a single mycobacterial antigen protects against leprosy infection.
    Martin E; Roche PW; Triccas JA; Britton WJ
    Vaccine; 2001 Jan; 19(11-12):1391-6. PubMed ID: 11163661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination and skin test studies on children living in villages with differing endemicity for leprosy and tuberculosis.
    Ghazi Saidi K; Stanford JL; Stanford CA; Dowlati Y; Farshchi Y; Rook GA; Rees RJ
    Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):45-53. PubMed ID: 2659701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Will new tuberculosis vaccines provide protection against leprosy?
    Richardus JH; Saunderson P; Smith C
    Int J Tuberc Lung Dis; 2011 Feb; 15(2):143. PubMed ID: 21219671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.